1. Home
  2. EMKR vs MYNZ Comparison

EMKR vs MYNZ Comparison

Compare EMKR & MYNZ Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • EMKR
  • MYNZ
  • Stock Information
  • Founded
  • EMKR 1984
  • MYNZ 2021
  • Country
  • EMKR United States
  • MYNZ Germany
  • Employees
  • EMKR N/A
  • MYNZ N/A
  • Industry
  • EMKR Semiconductors
  • MYNZ Biotechnology: Pharmaceutical Preparations
  • Sector
  • EMKR Technology
  • MYNZ Health Care
  • Exchange
  • EMKR Nasdaq
  • MYNZ Nasdaq
  • Market Cap
  • EMKR 9.8M
  • MYNZ 9.8M
  • IPO Year
  • EMKR 1997
  • MYNZ 2021
  • Fundamental
  • Price
  • EMKR $1.16
  • MYNZ $0.35
  • Analyst Decision
  • EMKR Buy
  • MYNZ Buy
  • Analyst Count
  • EMKR 2
  • MYNZ 2
  • Target Price
  • EMKR $15.00
  • MYNZ $3.00
  • AVG Volume (30 Days)
  • EMKR 903.2K
  • MYNZ 1.4M
  • Earning Date
  • EMKR 08-06-2024
  • MYNZ 08-13-2024
  • Dividend Yield
  • EMKR N/A
  • MYNZ N/A
  • EPS Growth
  • EMKR N/A
  • MYNZ N/A
  • EPS
  • EMKR N/A
  • MYNZ N/A
  • Revenue
  • EMKR $89,700,000.00
  • MYNZ $895,479.00
  • Revenue This Year
  • EMKR N/A
  • MYNZ $67.40
  • Revenue Next Year
  • EMKR $2.05
  • MYNZ $191.13
  • P/E Ratio
  • EMKR N/A
  • MYNZ N/A
  • Revenue Growth
  • EMKR 511.83
  • MYNZ 69.00
  • 52 Week Low
  • EMKR $0.78
  • MYNZ $0.32
  • 52 Week High
  • EMKR $8.50
  • MYNZ $4.71
  • Technical
  • Relative Strength Index (RSI)
  • EMKR 45.14
  • MYNZ 37.39
  • Support Level
  • EMKR $1.22
  • MYNZ $0.39
  • Resistance Level
  • EMKR $1.51
  • MYNZ $0.46
  • Average True Range (ATR)
  • EMKR 0.15
  • MYNZ 0.07
  • MACD
  • EMKR 0.00
  • MYNZ 0.01
  • Stochastic Oscillator
  • EMKR 12.50
  • MYNZ 13.88

About EMKR EMCORE Corporation

EMCORE Corp is a provider of sensors and navigation systems for the aerospace and defense market. The company operates in one reporting segment, Inertial Navigation, whose product technology categories include: (a) FOG, (b) QMEMS, (c) RLG, in each case which serve the aerospace and defense market. The company operates geographically in United States and Canada, which is the key revenue generator; Asia; Europe; and Other.

About MYNZ Mainz Biomed N.V.

Mainz Biomed NV develops market-ready molecular genetic diagnostic solutions for life-threatening conditions. The company's flagship product is ColoAlert, is an accurate, non-invasive and easy-to-use, early-detection diagnostic test for colorectal cancer based on real-time Polymerase Chain Reaction-based (PCR) multiplex detection of molecular-genetic biomarkers in stool samples.

Share on Social Networks: